OUR SPONSORS

ExThera Medical Corporation has developed the Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100), a broad-spectrum, extracorporeal pathogen filter for the rapid treatment of bloodstream infections. ExThera has completed a successful EU clinical trial and anticipates CE Mark by mid-2019. The company is led by an experienced team that has developed many novel biomaterials and pioneering medical devices and implants.